World's Best Scientists 2026 revealed!
Marc Ferrante

Marc Ferrante

D-Index & Metrics

Medicine

D-Index
86
Citations
37062
World Ranking
13908
National Ranking
172

Overview

Marc Ferrante is affiliated with KU Leuven in Belgium and conducts research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their scholarly focus includes significant contributions to Genetics, Epidemiology, Surgery, Immunology, and Oncology.

The research topics covered by Ferrante emphasize inflammatory and autoimmune conditions, particularly Inflammatory Bowel Disease. Other main topics include Microscopic Colitis, Eosinophilic Esophagitis, Immunodeficiency and Autoimmune Disorders, Autoimmune and Inflammatory Disorders, Chronic Lymphocytic Leukemia Research, and Biosimilars and Bioanalytical Methods.

Ferrante has contributed to several recent papers, including:

  • "Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial", 2022, The Lancet
  • "Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials", 2022, The Lancet
  • "European Crohn's and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation", 2022, Journal of Crohn s and Colitis
  • "Ulcerative colitis", 2020, Nature Reviews Disease Primers
  • "Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease", 2020, Gastroenterology

Frequent co-authors of Marc Ferrante include:

  • Séverine Vermeire
  • Bram Verstockt
  • João Sabino
  • Geert D'Haens
  • Silvio Danese

Ferrante often publishes in venues focused on gastroenterology and related specialties, with frequent appearances in:

  • Journal of Crohn s and Colitis
  • Gastroenterology
  • The American Journal of Gastroenterology
  • Clinical Gastroenterology and Hepatology
  • Inflammatory Bowel Diseases

Best Publications

  • Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.

    Toshiro Sato;Daniel E. Stange;Marc Ferrante;Marc Ferrante;Robert G.J. Vries

  • A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

    Kathleen Machiels;Marie Joossens;João Sabino;Vicky De Preter

  • Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial.

    Julián Panés;Damián García-Olmo;Gert Van Assche;Jean Frederic Colombel

  • Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

    Geert D'Haens;Marc Ferrante;Severine Vermeire;Filip Baert

  • Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

    Niels Vande Casteele;Marc Ferrante;Gert Van Assche;Vera Ballet

  • European evidence based consensus for endoscopy in inflammatory bowel disease

    Vito Annese;Marco Daperno;Matthew D. Rutter;Matthew D. Rutter;Aurelien Amiot

  • Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

    Fabian Schnitzler;Herma Fidder;Marc Ferrante;Maja Noman

  • Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort

    F Schnitzler;H Fidder;M Ferrante;M Noman

  • Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

    H Fidder;F Schnitzler;M Ferrante;M Noman

  • Influence of trough serum levels and immunogenicity on long-term outcome of adalimumab therapy in Crohn's disease.

    Konstantinos Karmiris;Gilles Paintaud;Maja Noman;Charlotte Magdelaine-Beuzelin

  • Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

    Brian G Feagan;William J Sandborn;Geert D'Haens;Julián Panés

  • Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

    Julián Panés;Damián García-Olmo;Gert Van Assche;Jean Frederic Colombel

  • Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening

    Matteo Boretto;Nina Maenhoudt;Xinlong Luo;Aurélie Hennes

  • Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

    João Guedelha Sabino;Sara Vieira-Silva;Kathleen Machiels;Marie Joossens

  • Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

    I. Arijs;K. Li;G. Toedter;R. Quintens

  • Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis

    David N. Moskovitz;Gert Van Assche;Benedikte Maenhout;Joris Arts

  • New serological markers in inflammatory bowel disease are associated with complicated disease behaviour

    Marc Ferrante;Liesbet Henckaerts;Marie Joossens;Marie Pierik

  • European evidence based consensus on surgery for ulcerative colitis.

    Tom Øresland;Willem A. Bemelman;Gianluca M. Sampietro;Antonino Spinelli

  • Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability

    Matteo Giovanni Maria Boretto;Benoit Cox;Manuel Noben;Nikolai Hendriks

  • Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.

    Séverine Vermeire;Marie Joossens;Marie Joossens;Kristin Verbeke;Jun Wang

Frequent Co-Authors

Jan Ceuppens
Jan Ceuppens KU Leuven
Ghislain Opdenakker
Ghislain Opdenakker Rega Institute for Medical Research
Paul Declerck
Paul Declerck KU Leuven
Menno P.J. de Winther
Menno P.J. de Winther University of Amsterdam
Bernd Arnold
Bernd Arnold German Cancer Research Center
Brian G. Feagan
Brian G. Feagan University of Western Ontario

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine or healthcare, there are many flexible online degrees and certifications to help you get started. For those interested in managing patient data and optimizing healthcare systems, online schools for health information management provide accredited programs where you can learn valuable administrative and technical skills.

Another popular pathway is medical coding and billing, which offers in-demand roles that support hospitals and clinics. It’s important to compare the medical coding certification cost so you can find an affordable program that fits your goals and budget.

For those aiming for advanced clinical roles, there are a variety of online nurse practitioner programs available. These programs allow registered nurses to further specialize and expand their career opportunities, often with a flexible schedule.

Lastly, aspiring nurses can explore online nursing courses that range from foundational certificates to full degree programs. These courses can be an accessible entry point into patient care roles and the broader healthcare field.

Best Scientists Citing Marc Ferrante

Trending Scientists

Recently Published Articles